Kontafarma China Holdings Ltd

01312

Company Profile

  • Business description

    Kontafarma China Holdings Ltd and its subsidiaries are principally engaged in the pharmaceutical and fitness business. The Group manufactures and sells prescription drugs, including chemical drugs, traditional Chinese medicine prescriptions, active pharmaceutical ingredients, and API intermediates in China, and operates fitness centres, provides fitness and health consultation services, and operates a franchise business for royalty fee income. Its segments are the pharmaceutical business, which generates maximum revenue, and the fitness business. The Group operates in Mainland China, Singapore, Taiwan, and other regions, with maximum revenue from Mainland China.

  • Contact

    30 Harbour Road
    Room 12A15-12A20, 12A Floor, Sun Hung Kai Centre
    Wanchai
    Hong Kong
    HKG

    T: +852 27316500

    http://www.kontafarma.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    616

Stocks News & Analysis

stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.
stocks

Turnaround progressing for ASX share

Margins have rebased by shares are undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,829.5017.300.20%
CAC 407,981.765.73-0.07%
DAX 4024,400.6592.730.38%
Dow JONES (US)49,558.05128.07-0.26%
FTSE 10010,330.556.800.07%
HKSE25,797.85122.670.48%
NASDAQ26,011.9878.76-0.30%
Nikkei 22560,550.59265.36-0.44%
NZX 50 Index12,974.32211.401.66%
S&P 5007,388.2014.85-0.20%
S&P/ASX 2008,604.7023.100.27%
SSE Composite Index4,169.5438.010.92%

Market Movers